Monday, December 1, 2008 - 11:22PM EST

General Interest Articles

11. Benign prostatic hyperplasia and subsequent risk of bladder cancer.

Author
Kang D; Chokkalingam AP; Gridley G; Nyren O; Johansson JE; Adami HO; Silverman D; Hsing AW;
Institution
[1] 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA [2] 2College of Medicine, Seoul National University, Seoul, Korea.
Journal
Br J Cancer. 2007 May 7;96(9):1475-9. Epub 2007 May 1.
Abstract URL
Click here to view abstract

12. Hospital Volume and Late Survival After Cancer Surgery.

Author
Birkmeyer JD; Sun Y; Wong SL; Stukel TA;
Institution
From the *Michigan Surgical Collaborative for Outcomes Research and Evaluation, Department of Surgery, University of Michigan, Ann Arbor, MI; and daggerInstitute for the Clinical Evaluative Sciences and Department of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Journal
Ann Surg. 2007 May;245(5):777-783.
Abstract URL
Click here to view abstract

13. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study.

Author
Denzinger S; Burger M; Walter B; Knuechel R; Roessler W; Wieland WF; Filbeck T;
Institution
Department of Urology, University of Regensburg, Regensburg, Germany. stefandenzinger@hotmail.com
Journal
Urology. 2007 Apr;69(4):675-9.
Abstract URL
Click here to view abstract

14. Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy.

Author
Horikawa Y; Kumazawa T; Narita S; Inoue T; Yuasa T; Matsuura S; Nanjo H; Satoh S; Tsuchiya N; Habuchi T;
Institution
Department of Urology, Akita University School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan, thabuchi@doc.med.akita-u.ac.jp.
Journal
Int J Clin Oncol. 2007 Apr;12(2):131-6. Epub 2007 Apr 27.
Abstract URL
Click here to view abstract

15. Use of urinary biomarkers for bladder cancer surveillance: patient perspectives.

Author
Yossepowitch O; Herr HW; Donat SM;
Institution
Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Journal
J Urol. 2007 Apr;177(4):1277-82; discussion 1282.
Abstract URL
Click here to view abstract

16. Molecular therapeutic targets for bladder cancer.

Author
Zacharakis E; Monem M; Joseph JV; Patel HR;
Institution
Journal
Expert Rev Anticancer Ther. 2007 Dec;7(12):1691-3.

17. Holmium laser treatment for low grade, low stage, noninvasive bladder cancer with local anesthesia and early instillation of mitomycin C.

Author
Soler-Martinez J; Vozmediano-Chicharro R; Morales-Jimenez P; Hernandez-Alcaraz D; Vivas-Vargas E; Santos Garcia-Vaquero I; Baena-Gonzalez V;
Institution
Servicio de Urologia, Hospital Regional Universitario Carlos Haya, Malaga, Spain. jorge_soler_martinez@yahoo.es
Journal
J Urol. 2007 Dec;178(6):2337-9. Epub 2007 Oct 22.
Abstract URL
Click here to view abstract

18. Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer.

Author
Chen CH; Shun CT; Huang KH; Huang CY; Tsai YC; Yu HJ; Pu YS;
Institution
Department of Urology, National Taiwan University Hospital, Taipei, Taiwan.
Journal
BJU Int. 2007 Aug;100(2):281-6; discussion 286. Epub 2007 Apr 5.
Abstract URL
Click here to view abstract

19. Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI).

Author
Gilbert SM; Wood DP; Dunn RL; Weizer AZ; Lee CT; Montie JE; Wei JT;
Institution
Department of Urology, Divisions of Health Services Research and Urologic Oncology, University of Michigan, Ann Arbor, Michigan.
Journal
Cancer. 2007 Mar 15;109(9):1756-1762.
Abstract URL
Click here to view abstract

20. Lack of progress in early diagnosis of bladder cancer.

Author
Araki M; Nieder AM; Manoharan M; Yang Y; Soloway MS;
Institution
Department of Urology, University of Miami Miller School of Medicine, Miami Beach, Florida 33140, USA.
Journal
Urology. 2007 Feb;69(2):270-4.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4